Drug regulator calls for cancelling licence of firm related to Uzbek deaths | Latest News India - Hindustan Times
close_game
close_game

Drug regulator calls for cancelling licence of Noida-based firm linked to Uzbek deaths

Mar 05, 2023 05:02 AM IST

Marion Biotech’s Dok-1 cough syrups allegedly led to the deaths of the children in December 2022. Noida police on Friday arrested three officials of the company on the basis of an FIR lodged by the Central Drugs Standard Control Organization (CDSCO).

Noida: The central drug regulator has recommended cancellation of the licence of Noida-based pharmaceutical firm Marion Biotech, whose cough syrup has been linked to the deaths of 18 children in Uzbekistan, after an analysis found that its products did not meet quality standards, officials from the state and the Centre said on Saturday.

Noida police on Friday arrested three officials of the Noida-based pharmaceutical firm Marion Biotech on the basis of an FIR lodged by the Central Drugs Standard Control Organization (CDSCO) in connection with an ongoing investigation that found Marion’s product samples adulterated and not of standard quality (REUTERS)
Noida police on Friday arrested three officials of the Noida-based pharmaceutical firm Marion Biotech on the basis of an FIR lodged by the Central Drugs Standard Control Organization (CDSCO) in connection with an ongoing investigation that found Marion’s product samples adulterated and not of standard quality (REUTERS)

Noida police on Friday arrested three officials of the company on the basis of an FIR lodged by the Central Drugs Standard Control Organization (CDSCO) in connection with an ongoing investigation that found Marion’s product samples adulterated and not of standard quality. Marion Biotech’s Dok-1 cough syrups allegedly led to the deaths of the children in December 2022.

Hindustan Times - your fastest source for breaking news! Read now.

ALSO READ: Marion syrup ingredients under lens over Uzbekistan deaths

“The CDSCO has made a recommendation to the licencing authority, which is the state drug control department, to cancel the company’s licence. We are reviewing paperwork and have initiated the process,” Gautam Buddh Nagar’s drug inspector Vaibhav Babbar said.

Speaking on condition of anonymity, a central government official said that during investigation it was found that the firm was not following regulatory guidelines.

“Investigations have found that Marion Biotech’s manufacturing practices were flawed. While they do not supply their drugs in the Indian market, they will have to recall their products from the countries where they have operations. The state enforcement agencies have already started the process of licence cancellation,” the official said.

HT tried to reach out to the firm’s officials, but couldn’t get a response immediately.

The FIR against the company said that central and state drug authorities checked samples of Marion Biotech’s drugs during joint inspections on December 27, 29 and 30. These were sent to the government’s regional drug testing laboratory in Chandigarh and 22 of the samples were found to be “not of standard quality”

“The government analyst of Regional Drugs Testing Laboratory, Chandigarh, vide test report CHD/LS/22-23/380 dated 14.01.2023 has declared the subject sample to be ‘Not of Standard Quality’ for the reasons that the sample does not conform to claim as per Patent and Proprietary…” read the CDSCO letter to the company, seen by HT.

According to people familiar with the matter, the company was also violating schedule M- good manufacturing practices in production, and its licence was suspended in January.

WHO also issued a “medical product alert”, referring to two substandard (contaminated) products, identified in Uzbekistan and reported to it on December 22, 2022. The WHO statement added that the samples of both products tested by the Ministry of Health of the Republic of Uzbekistan found they contained “unacceptable amounts of diethylene glycol and /or ethylene glycol as contaminants”. It further mentioned that diethylene glycol and ethylene glycol are toxic to humans when consumed and can prove fatal.

Besides Dok-1 cough syrup, Haryana-based Maiden Pharmaceuticals’s cough syrup and Chennai-based Global Pharma Healthcare Pvt Ltd’s eye drops are in a global controversy over possible contamination.

(With inputs from New Delhi)

Unveiling Elections 2024: The Big Picture', a fresh segment in HT's talk show 'The Interview with Kumkum Chadha', where leaders across the political spectrum discuss the upcoming general elections. Watch now!

Get Current Updates on India News, Election 2024, Arvind Kejriwal News Live, Bihar Board 10th Result 2024 Live along with Latest News and Top Headlines from India and around the world.
SHARE THIS ARTICLE ON
Share this article
SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Thursday, March 28, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On